Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
Paola Mapelli, Stefano Partelli, Matteo Salgarello, et al.
Diagnostics (2021) Vol. 11, Iss. 2, pp. 192-192
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications
Kiersten Preuss, Nate Thach, Xiaoying Liang, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1654-1654
Open Access | Times Cited: 48
Clinical Utility of 18F-FDG PET in Neuroendocrine Tumors Prior to Peptide Receptor Radionuclide Therapy: A Systematic Review and Meta-Analysis
Emmanouil Alevroudis, Maria-Eleni Spei, Sofia Chatziioannou, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1813-1813
Open Access | Times Cited: 44
Update of the diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours) [Aktualizacja zaleceń ogólnych dotyczących postępowania diagnostyczno-terapeutycznego w nowotworach neuroendokrynnych układu pokarmowego (rekomendowane przez Polską Sieć Guzów Neuroendokrynnych)]
Beata Kos‐Kudła, Wanda Fołtyn, Anna Malczewska, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 387-454
Open Access | Times Cited: 35
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours
Paola Mapelli, Carolina Bezzi, Diego Palumbo, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 7, pp. 2352-2363
Closed Access | Times Cited: 30
Dual-Tracer PET Image Separation by Deep Learning: A Simulation Study
Bailin Pan, Paul Marsden, Andrew J. Reader
Applied Sciences (2023) Vol. 13, Iss. 7, pp. 4089-4089
Open Access | Times Cited: 12
Pancreatic neuroendocrine neoplasms — update of the diagnostic and therapeutic guidelines (recommended by the Polish Network of Neuroendocrine Tumours) [Nowotwory neuroendokrynne trzustki — uaktualnione zasady diagnostyki i leczenia (rekomendowane przez Polską Sieć Guzów Neuroendokrynych)]
Beata Kos‐Kudła, Violetta Rosiek, Małgorzata Borowska, et al.
Endokrynologia Polska (2022) Vol. 73, Iss. 3, pp. 491-548
Open Access | Times Cited: 18
Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists
Fabio Pellegrino, Vincenza Granata, Roberta Fusco, et al.
Tomography (2023) Vol. 9, Iss. 1, pp. 217-246
Open Access | Times Cited: 10
[68Ga]-DOTATOC PET/CT Volumetric Parameters Reflect Metastatic Potential in Pancreatic Neuroendocrine Tumors
So Jeong Kim, Jongtae Cha, Hee Seung Lee, et al.
Cancers (2025) Vol. 17, Iss. 9, pp. 1487-1487
Open Access
Deep Learning-based Triple-Tracer Brain PET Scanning in a Single Session: A simulation study using clinical data
Yiyi Hu, Amirhossein Sanaat, Gregory Mathoux, et al.
NeuroImage (2025), pp. 121246-121246
Open Access
Emerging innovations in theranostics for pancreatic neuroendocrine tumors
Anita Karimi, Christina Bogdani, Elisabeth O’Dwyer, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
[18F]FDG PET/CT–Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study
David L. Chan, Aimee R. Hayes, Ioannis Karfis, et al.
Journal of Nuclear Medicine (2023) Vol. 65, Iss. 2, pp. 185-191
Open Access | Times Cited: 8
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms
Anna Battistella, Matteo Tacelli, Paola Mapelli, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 4-5, pp. 155-169
Closed Access | Times Cited: 2
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours
Paola Mapelli, Carolina Bezzi, Francesca Muffatti, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 9, pp. 2774-2783
Closed Access | Times Cited: 2
Prognostic Implications of PET-Derived Tumor Volume and Uptake in Patients with Neuroendocrine Tumors
Manuel Weber, Tuğçe Telli, David Kersting, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3581-3581
Open Access | Times Cited: 6
Preoperative prediction of pancreatic neuroendocrine tumor grade based on 68Ga-DOTATATE PET/CT
Jiao Ma, Xiaoyong Wang, Mingsong Tang, et al.
Endocrine (2023) Vol. 83, Iss. 2, pp. 502-510
Open Access | Times Cited: 6
Neuroendocrine Tumor Diagnosis
Heying Duan, Andrei Iagaru
PET Clinics (2023) Vol. 18, Iss. 2, pp. 259-266
Closed Access | Times Cited: 5
PET-CT in Clinical Adult Oncology—VI. Primary Cutaneous Cancer, Sarcomas and Neuroendocrine Tumors
G Fine, Matthew F. Covington, Bhasker R. Koppula, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 2835-2835
Open Access | Times Cited: 8
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness
Carolina Bezzi, Alice Bergamini, Gregory Mathoux, et al.
Cancers (2023) Vol. 15, Iss. 1, pp. 325-325
Open Access | Times Cited: 3
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors
Paola Mapelli, Carolina Bezzi, Francesca Muffatti, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 9, pp. 2818-2829
Closed Access | Times Cited: 3
The progress of PET/MRI in clinical management of patients with pancreatic malignant lesions
Jindan Li, Chaojiang Fu, Sheng Zhao, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios
Katerina Konstantinoff, Ajaykumar C. Morani, Thomas A. Hope, et al.
Abdominal Radiology (2023) Vol. 48, Iss. 5, pp. 1843-1853
Closed Access | Times Cited: 2
Case Report: Giant insulinoma, a very rare tumor causing hypoglycemia
Georges Tarris, Alexia Rouland, Kévin Guillen, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 2
Peptide receptor radionuclide therapy as a tool for the treatment of severe hypoglycemia in patients with primary inoperable insulinoma
Marta Opalińska, Anna Sowa‐Staszczak, Ibraheem Al Maraih, et al.
Bio-Algorithms and Med-Systems (2021) Vol. 17, Iss. 4, pp. 221-226
Closed Access | Times Cited: 4
Enucleation of Benign, Neuroendocrine Tumors of the Pancreas
Frank Weber, Andreas Machens, Henning Dralle
Pancreas (2023), pp. 833-840
Closed Access | Times Cited: 1
The diagnostic value of combining preoperative serum CA19-9, ALBI score, and 18F-FDG PET/CT imaging in preoperative resectability of pancreatic cancer
Shu‐Li Yang, Ruixue Ma, Jing Wu
Nuclear Medicine Communications (2024)
Closed Access
Page 1 - Next Page

Scroll to top